These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 23229111)
1. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines. Zhuo L; Liu J; Wang B; Gao M; Huang A Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111 [TBL] [Abstract][Full Text] [Related]
2. [Morphology and microRNA expression profiles of drug-resistant cells in hepatocellular carcinoma]. Zhuo LJ; Chen H; Wu MX; Gao MQ; Chen SP; Huang AM Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):604-8. PubMed ID: 24314246 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells. Husted S; Søkilde R; Rask L; Cirera S; Busk PK; Eriksen J; Litman T Mol Pharm; 2011 Dec; 8(6):2055-62. PubMed ID: 21899346 [TBL] [Abstract][Full Text] [Related]
4. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells. Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest. Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841 [TBL] [Abstract][Full Text] [Related]
6. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663 [TBL] [Abstract][Full Text] [Related]
7. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Qin J; Luo M; Qian H; Chen W Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717 [TBL] [Abstract][Full Text] [Related]
8. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells. Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051 [TBL] [Abstract][Full Text] [Related]
9. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
11. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Yang L; Li N; Wang H; Jia X; Wang X; Luo J Oncol Rep; 2012 Aug; 28(2):592-600. PubMed ID: 22614869 [TBL] [Abstract][Full Text] [Related]
12. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes]. Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984 [TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs in drug-resistant ovarian cancer cells. Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650 [TBL] [Abstract][Full Text] [Related]
14. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs. Xu Y; Xie Y; Wang X; Chen X; Liu Q; Ying M; Zheng Q Oncol Rep; 2013 Nov; 30(5):2056-62. PubMed ID: 24002436 [TBL] [Abstract][Full Text] [Related]
15. Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine. Mutlu P; Ural AU; Gündüz U Biomed Pharmacother; 2012 Oct; 66(7):506-11. PubMed ID: 22681910 [TBL] [Abstract][Full Text] [Related]
16. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance. Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364 [TBL] [Abstract][Full Text] [Related]
20. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]